These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 94520)

  • 1. Fluorescence-activated separation of cervical abnormal cells using herpesvirus antigenic markers.
    Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Smith CC; Tyrer HW; Mantione JM; Albright CD
    Anal Quant Cytol; 1979; 1(2):89-102. PubMed ID: 94520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC; Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Klacsmann K; Geddes S
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
    Meng XJ
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluorometric quantitation of size, deoxyribonucleic acid and viral antigenic determinants in cells productively infected with HSV-2.
    Aurelian L; Tyrer HW; Gupta PK; Frost JK; Adams LA; Tiffany SM
    Anal Quant Cytol; 1979; 1(3):207-16. PubMed ID: 94525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HSV-2 antigen in carcinoma cervix and premalignant conditions by immuno-cytochemistry.
    Pandit AA; Khilnani PH; Powar H; Bhave GG; Chadda NO
    J Postgrad Med; 1990 Oct; 36(4):185-90. PubMed ID: 2132242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
    Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
    J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine arabinoside (ARA-A) blocked HSV-2 infected human skin fibroblasts as targets for the detection of serum mediated and cellular cytotoxicity in patients with cervical carcinoma.
    Paulileinikki ES; Vesterinen E
    Clin Exp Immunol; 1976 Aug; 25(2):264-9. PubMed ID: 182421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
    Kawana T; Sakamoto S; Kasamatsu T; Aurelian L
    Gan; 1978 Aug; 69(4):589-91. PubMed ID: 710808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer.
    Costa S; D'Errico A; Grigioni WF; Orlandi C; Smith CC; Mancini AM; Aurelian L
    Cancer Detect Prev Suppl; 1987; 1():189-205. PubMed ID: 2826000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral etiology of cervical carcinoma. Human papilloma virus and herpes simplex virus type 2.
    Meng XJ; Sun Y; Chen MH; Liu ZH; Zhang YX; Li XZ; Li K; Han RC; Si JY; Hu LY
    Chin Med J (Engl); 1989 Feb; 102(2):94-9. PubMed ID: 2550184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
    Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
    Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.